Diagnostic approach in acute hypoxemic respiratory failure DOI Creative Commons
Pierre Bay, Nicolas de Prost

Journal of Intensive Medicine, Journal Year: 2024, Volume and Issue: 5(2), P. 119 - 126

Published: Nov. 8, 2024

Acute hypoxemic respiratory failure (AHRF) is the leading cause of intensive care unit (ICU) admissions. Of patients with AHRF, 40 %-50 % will require invasive mechanical ventilation during their stay in ICU, and 30 %-80 meet Berlin Criteria for Respiratory Distress Syndrome (ARDS). Rapid identification underlying AHRF necessary before initiating targeted treatment. Almost 10 ARDS have no identified classic risk factors however, precise may not be up to 15 patients, particularly cases immunosuppression. In these a multidisciplinary, comprehensive, hierarchical diagnostic work-up mandatory, including detailed history physical examination, chest computed tomography, extensive microbiological investigations, bronchoalveolar lavage fluid cytological analysis, immunological tests, investigation possible involvement pneumotoxic drugs.

Language: Английский

Immune Checkpoint Inhibitors for Pediatric Cancers: Is It Still a Stalemate? DOI Creative Commons
Tang‐Her Jaing, Yi-Lun Wang,

Chia-Chi Chiu

et al.

Pharmaceuticals, Journal Year: 2024, Volume and Issue: 17(8), P. 991 - 991

Published: July 26, 2024

The knowledge surrounding the application of immune checkpoint inhibitors (ICIs) in treatment pediatric cancers is continuously expanding and evolving. These therapies work by enhancing body's natural response against tumors, which may have been suppressed certain pathways. effectiveness ICIs treating adult has widely acknowledged. However, results early phase I/II clinical trials that exclusively targeted use for different underwhelming. rates to generally modest, except cases classic Hodgkin lymphoma. There seems be a notable disparity immunogenicity childhood compared cancers, potentially accounting this phenomenon. On average, tend significantly fewer neoantigens. In recent times, there renewed sense optimism regarding potential benefits ICI specific groups children with cancer. initial research, individuals diagnosed hypermutated SMARCB1-deficient shown remarkable positive outcomes when treated therapies. This likely due underlying biological factors promote expression neoantigens inflammation within tumor. Ongoing are diligently assessing cancer patients these subsets. review aimed analyze safety types highly advanced malignancies.

Language: Английский

Citations

0

Simple theranostics nanoagent for precision suppression of tumor growth and Metastasis: A traditional fermented product having a novel functional breakthrough DOI

Pengmin Liu,

Rong Dai,

Juan Li

et al.

Chemical Engineering Journal, Journal Year: 2024, Volume and Issue: 500, P. 156545 - 156545

Published: Oct. 10, 2024

Language: Английский

Citations

0

Diagnostic approach in acute hypoxemic respiratory failure DOI Creative Commons
Pierre Bay, Nicolas de Prost

Journal of Intensive Medicine, Journal Year: 2024, Volume and Issue: 5(2), P. 119 - 126

Published: Nov. 8, 2024

Acute hypoxemic respiratory failure (AHRF) is the leading cause of intensive care unit (ICU) admissions. Of patients with AHRF, 40 %-50 % will require invasive mechanical ventilation during their stay in ICU, and 30 %-80 meet Berlin Criteria for Respiratory Distress Syndrome (ARDS). Rapid identification underlying AHRF necessary before initiating targeted treatment. Almost 10 ARDS have no identified classic risk factors however, precise may not be up to 15 patients, particularly cases immunosuppression. In these a multidisciplinary, comprehensive, hierarchical diagnostic work-up mandatory, including detailed history physical examination, chest computed tomography, extensive microbiological investigations, bronchoalveolar lavage fluid cytological analysis, immunological tests, investigation possible involvement pneumotoxic drugs.

Language: Английский

Citations

0